OCTAGON CAPITAL ADVISORS LP Alnylam Pharmaceuticals, Inc. Transaction History

OCTAGON CAPITAL ADVISORS LP portfolio value:

$7.46M
portfolio value

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 37.3K shares 7.46M $200.16 37.3K